A circRNA-miRNA-mRNA network analysis underlying pathogenesis of human heart failure

Ran Xu1, Jian Wu1, Chun-Jie Yang1

  • 1Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China.

Insights

Circular RNAs (circRNAs) show distinct expression patterns in the heart and are involved in heart failure (HF) pathogenesis. This study identifies key circRNAs and their regulatory networks, offering insights into HF molecular mechanisms.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Non-coding RNA Research

Background:

  • Heart failure (HF) molecular mechanisms remain incompletely understood.
  • Circular RNAs (circRNAs) are increasingly recognized in cardiac tissue.
  • This study investigates the potential role of circRNAs in HF.

Purpose of the Study:

  • To characterize circRNA expression in the heart.
  • To identify differentially expressed circRNAs (DECs) in HF.
  • To explore the circRNA-miRNA regulatory network in HF.

Main Methods:

  • RNA sequencing to profile cardiac circRNAs.
  • Bioinformatic analysis to identify DECs and host genes.
  • Gene Ontology analysis for pathway enrichment.
  • Construction of a circRNA-miRNA interaction network.

Main Results:

  • Majority of cardiac circRNAs are <2000 nt; chromosome 1 has most, Y chromosome has least.
  • Identified 238 DECs and 203 host genes; only 4 host genes overlap with known HF DEGs.
  • Enriched pathways include immune system, metabolism, and signal transduction; identified 1052 targeted miRNAs.
  • Constructed a circRNA-miRNA network revealing complex regulatory interactions.

Conclusions:

  • CircRNAs exhibit species and tissue-specific expression.
  • CircRNA expression is independent of host genes, but DECs and DEGs share functional pathways in HF.
  • Findings advance understanding of circRNAs' role in HF and provide a basis for future research.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
20
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
708
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
14
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
18